Kiromic Biopharma Inc (KRBP) — Defensive Interval Ratio

Latest as of December 2022: 0 days

Kiromic Biopharma Inc (KRBP) has a Defensive Interval Ratio of 0 days as of December 2022. Defensive assets of $0.00 (cash $-, short-term investments $-, receivables $0.00) cover 0 days of daily cash needs of $36.39K/day. See Kiromic Biopharma Inc (KRBP) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

0 days
Days of operational coverage

Defensive Assets

$0.00
Cash + ST Investments + Receivables

Daily Cash Need

$36.39K
Current Liabilities ÷ 365

Current Liabilities

$13.28 Million
USD

Kiromic Biopharma Inc Defensive Interval Ratio (2018–2022)

This chart shows how Kiromic Biopharma Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2018 to 2022. As of December 2022, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See Kiromic Biopharma Inc balance sheet quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Kiromic Biopharma Inc (2018–2022)

The table below presents the year-by-year Defensive Interval Ratio for Kiromic Biopharma Inc from 2018 to 2022, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Kiromic Biopharma Inc market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2022 0 days $0.00 $36.39K/day $- $- ▼ -2 days
2021 2 days $16.20K $9.34K/day $- $- ▲ +2 days
2020 0 days $0.00 $4.02K/day $- $- ▼ -15 days
2018 15 days $24.30K $1.67K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)